Medicina de precisión a escala nanométrica

Magnobot Med has been founded on the belief that medicine should be precise and minimally invasive, our company develops nanorobotic technology for the medical field. Our nanorobots are World’s smallest medical robots (size ~ 120 nanometers) secured/holding Guinness World record in 2018. Our flagship application is precision drug delivery: our nanorobots carry therapeutic payloads directly to diseased cells, such as tumors, and release them only in response to external triggers, significantly reducing the systemic toxicity associated with conventional chemotherapy. Beyond cancer therapy, our research and development pipeline extends to minimally invasive surgery, clearing arterial plaques and blood clots, early disease detection and spinal cord regeneration. Using external magnetic fields, our systems can be guided with accuracy through complex vascular environments. We are committed to addressing the field’s key challenges, including immune system clearance, long-term biocompatibility, scalable and reproducible manufacturing, real-time in vivo tracking, and the development of sound regulatory and ethical frameworks. While our work is currently at the preclinical and early clinical stage, we are driven by a clear vision: to reshape diagnostics and personalized therapy for the coming decades and bring safer, smarter treatment to patients everywhere.